The Oral-Systemic Infrastructure Market Is Starting to Form

CareQuest's central market-formation test is straightforward: unmet need alone does not create an investable market. Momentum is strongest when the problem is urgent, customers are already prioritizing it, the infrastructure can support adoption, and outcomes or economics can be measured.

That is a useful discipline for oral-systemic health because the category can otherwise become a collection of compelling associations. Diabetes, cardiovascular disease, pregnancy, respiratory risk and other conditions all create reasons to study the mouth as part of whole-person health. But a market forms only when those signals become operational: someone identifies the patient, someone acts, information moves, a referral closes, a service gets paid for, and the outcome can be measured.

The report places workflow-integrated AI in its strongest category, a hot spot, because need, customer demand, infrastructure readiness and capital activity are already strong. By contrast, medical-dental integration and prevention are characterized as bright spots: the need is strong and the value case is emerging, but customer demand and infrastructure are less mature.

The strongest Oral Signal takeaway is CareQuest's framing of medical-dental integration as an infrastructure problem. The report argues that integration only scales when information moves, referrals close, payment supports the work and follow-up is accountable.

That framing is more precise than the usual language about 'connecting oral and overall health.' It identifies the actual product categories required to make integration operational: health-information exchange, electronic record connectivity, referral infrastructure, medical billing pathways, credentialing, quality measurement and payer-provider data exchange.

CareQuest and Kno2 provide a concrete example. Their March 2026 initiative is designed to connect dental care to national health-information exchange infrastructure. Two electronic dental record platforms representing roughly 20% of the dental market committed as flagship partners, with stated goals around faster production deployment and provider adoption.

Open Dental subsequently became the first dental practice management system to connect through Kno2's network. This is strategically important because it suggests one path for integration does not require dentistry to abandon its existing systems. Instead, the connective layer can bring legacy dental infrastructure into the broader healthcare network.

PDS Health represents another model. Rather than adding an external interoperability layer to a traditional dental environment, PDS has invested directly in shared Epic infrastructure, medical-dental care models, screening workflows and payer partnerships. CareQuest's report explicitly treats PDS as an example of integration being operationalized inside a dental enterprise.

These approaches are not mutually exclusive. A fragmented dental market will likely require several deployment models: shared EHRs for some organizations, interoperability layers for others, and payer-mediated data exchange where clinical systems remain separate.

CareQuest's prevention and early-detection section is equally important because it highlights a mismatch: the clinical and economic rationale for earlier intervention is meaningful, but the infrastructure for scalable adoption remains thin.

Periodontal disease is the clearest example. The report cites an estimated 42% prevalence among U.S. adults age 30 and older, including 8% with severe disease. It also points to the 2023 JADA claims analysis showing periodontal treatment among people with diabetes was associated with 12% lower overall healthcare costs in commercial insurance and 14% lower costs in Medicaid.

Those data are not proof that periodontal treatment caused the savings, but they explain why payers and integrated-care organizations have a rational reason to test earlier identification and intervention in high-risk populations.

The infrastructure gap is what makes the category interesting. Risk scores, salivary tests and chairside screening do not create value on their own. They need a next step: a covered intervention, a referral pathway, longitudinal monitoring, documentation and a reimbursement mechanism.

CareQuest highlights Firstgrin as one example of prevention producing a measurable engagement outcome. In a DentaQuest pilot involving roughly 1,000 Louisiana Medicaid families, the program reported a 3.5-fold increase in first dental visits before age one. The point is not that every prevention model will replicate that result. It is that the category becomes more credible when the intervention, target population and measurable behavior are explicit.

The report also points to dental settings expanding beyond oral screening. CareQuest and PDS Health launched a six-month blood-pressure screening initiative across five dental practices in three states, targeting 10,000 patients. Another initiative is testing diabetes screening during routine dental hygiene visits. These are early models, but they show how dental visits can become access points for broader risk identification.

CareQuest reports that 43% of dentists were using AI for at least one task in Q2 2026, with another 26% planning to use it. Current use is concentrated in imaging and diagnostics, while planned adoption is moving toward administrative functions such as insurance verification.

The report's distinction is important: the hot spot is not AI in the abstract. It is AI embedded in core clinical and operational workflows.

Overjet illustrates that progression. What began as image-analysis and diagnostic support has expanded across documentation, claims review, patient communication, risk scoring and payer-provider alignment. Its Dental Clarity Network, joined by MetLife, Humana and Guardian, is explicitly aimed at improving the flow of coverage information and reducing manual clinical review for qualifying procedures.

LightSpun represents the payer-side version of the same thesis. It is moving AI into claims, benefits, provider data, credentialing and dental-plan infrastructure, where value can be measured through speed, accuracy and administrative cost.

For Oral Signal, these companies matter less as 'dental AI' vendors than as infrastructure providers. Their relevance increases when the output of a diagnostic system can feed a payer decision, a referral, a population-health model or a broader healthcare record.

CareQuest's framework suggests a more useful way to think about the category. Instead of grouping companies only by product type, Oral Signal should track the stage of market formation around each problem.

For every oral-systemic opportunity, five questions matter. Is the problem large and meaningfully unmet? Is there credible clinical or economic value? Is a defined buyer already spending? Are the workflows, reimbursement paths, data connections and policy conditions ready? And are investors, incumbents or strategic partners committing resources?

That creates a more decision-useful market map than a logo cloud. It explains why some clinically compelling areas remain commercially early, and why relatively unglamorous infrastructure can become more valuable than a novel diagnostic.

The next phase of Oral Signal will use this market-formation lens across the Payer Innovation Tracker, Diagnostics & Biomarkers Market Map and Medical-Dental Integration Tracker.

The most important signals will be movement across stages: a pilot that becomes a recurring benefit, an EHR integration that reaches production scale, a screening program that closes the referral loop, a diagnostic that gets reimbursed, or an observational savings signal that is tested prospectively.

CareQuest's 2026 report does not prove that the oral-systemic market has arrived. It shows something more useful: where the foundations are becoming visible. The emerging category is not simply 'oral health innovation.' It is the infrastructure that allows oral-health information, interventions and economics to function inside the rest of healthcare.